LON:DXRX Diaceutics (DXRX) Share Price, News & Analysis GBX 124 -0.81 (-0.65%) As of 10:40 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock About Diaceutics Stock (LON:DXRX) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Diaceutics alerts:Sign Up Key Stats Today's Range 123▼ 12650-Day Range 108▼ 14052-Week Range 106▼ 151Volume26,550 shsAverage Volume122,449 shsMarket Capitalization£104.65 millionP/E RatioN/ADividend YieldN/APrice TargetGBX 160Consensus RatingBuy Company OverviewAt Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world's leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX - The Diagnostics Network®.Read More… Receive DXRX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Diaceutics and its competitors with MarketBeat's FREE daily newsletter. Email Address DXRX Stock News HeadlinesDiaceutics PLC (LON:DXRX) Insider Sells £630,000 in StockMay 16, 2025 | insidertrades.comDiaceutics Enhances Employee Incentives with Share PurchasesJune 6, 2025 | tipranks.comTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.June 16, 2025 | Porter & Company (Ad)Diaceutics (LON:DXRX) Shares Up 2.3% - Should You Buy?June 6, 2025 | americanbankingnews.comDiaceutics PLC Announces AGM and Annual Report ReleaseMay 21, 2025 | tipranks.comDiaceutics PLC Expands Employee Share Incentive PlanApril 29, 2025 | tipranks.comDiaceutics PLC Enhances Employee Shareholding with New Share Incentive PlanApril 3, 2025 | tipranks.comDiaceutics PLC Aligns Employee Incentives with Share AwardsMarch 3, 2025 | tipranks.comSee More Headlines DXRX Stock Analysis - Frequently Asked Questions How have DXRX shares performed this year? Diaceutics' stock was trading at GBX 123 at the beginning of 2025. Since then, DXRX shares have increased by 0.8% and is now trading at GBX 124. View the best growth stocks for 2025 here. How were Diaceutics' earnings last quarter? Diaceutics PLC (LON:DXRX) announced its earnings results on Tuesday, May, 13th. The company reported ($2.02) EPS for the quarter. Diaceutics had a negative net margin of 10.90% and a negative trailing twelve-month return on equity of 7.15%. How do I buy shares of Diaceutics? Shares of DXRX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Diaceutics own? Based on aggregate information from My MarketBeat watchlists, some other companies that Diaceutics investors own include 4D pharma (DDDD), Rolls-Royce Holdings plc (RR.L), Abcam (ABC), B&M European Value Retail (BME), BP (BP), Coats Group (COA) and genedrive (GDR). Company Calendar Last Earnings5/13/2025Today6/16/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolLON:DXRX CIKN/A Webwww.diaceutics.com PhoneN/AFaxN/AEmployees151Year FoundedN/APrice Target and Rating Average Stock Price TargetGBX 160 High Stock Price TargetGBX 160 Low Stock Price TargetGBX 160 Potential Upside/Downside+29.0%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)GBX (3.37) Trailing P/E RatioN/A Forward P/E Ratio122.68 P/E GrowthN/ANet Income-£2.84 million Net Margins-10.90% Pretax MarginN/A Return on Equity-7.15% Return on Assets-6.06% Debt Debt-to-Equity Ratio0.39 Current Ratio4.85 Quick Ratio9.92 Sales & Book Value Annual Sales£26.08 million Price / Sales4.01 Cash FlowGBX 39.75 per share Price / Cash Flow3.12 Book ValueGBX 45.87 per share Price / Book2.70Miscellaneous Outstanding Shares84,393,829Free FloatN/AMarket Cap£104.65 million OptionableNot Optionable Beta0.58 7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.Get This Free Report This page (LON:DXRX) was last updated on 6/16/2025 by MarketBeat.com Staff From Our PartnersWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredSomething Big Is Coming...Man who predicted Lehman Crash Warns "Get OUT of Cash" He predicted the 2008 crisis and recommended shortin...Stansberry Research | SponsoredBREAKING: Trump vs. Elon Feud Threatens Your Retirement – Protect Yourself NOW"This isn't just a war of words. This is a financial time bomb. The escalating battle between Donald Trump a...American Alternative | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Diaceutics PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Diaceutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.